This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O'Neal, M. A. Articles by Griffin, A. C. Search for Related Content PubMed PubMed Citation Articles by O'Neal, M. A. Articles by Griffin, A. C.

The Effect of Oxypsoralen upon Ultraviolet Carcinogenesis in Albino Mice^*

( University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Texas)

1. The effect of 8-methoxypsoralen upon ultraviolet skin carcinogenesis in mice has been studied. This compound produces an increased photosensitivity of the skin, and also absorbs strongly in the ultraviolet wavelengths. Swiss mice were exposed to the total irradiation from ultraviolet lamps for 15 minutes per day. 8-Methoxypsoralen was administered in the diet or intraperitoneally.

2. The final incidence of ear tumors in mice receiving dietary 8-methoxypsoralen was considerably less than that of the controls. The extent of protection afforded by this compound appeared to be proportional to its concentration in the diet, up to an optimal level.

3. Those mice receiving intraperitoneal injections of 8-methoxypsoralen 1 hour prior to ultraviolet exposure exhibited early severe erythema. The final ear tumor incidence was nearly 100 per cent, as compared with 68 per cent in the control group. An accelerated latent period of carcinogenesis was also observed. If the compound was administered 20 hours before irradiation, the final ear tumor incidence was in the same range as that of the controls.

4. These findings are discussed with respect to wave length, erythemal response, dose level, and time of administration of the compounds.

^* A preliminary report of these findings was presented at the annual meeting of the American Association for Cancer Research, Atlantic City, New Jersey, April, 1956.

Received 5/31/57.

This article has been cited by other articles:

				R. Roelandts Mutagenicity and Carcinogenicity of Methoxsalen Plus UV-A Arch Dermatol, May 1, 1984; 120(5): 662 - 669. [Abstract] [PDF]

				A. J. Cox and E. A. Abel Epidermal Dystrophy: Occurrence After Psoriasis Therapy With Psoralen and Long-wave Ultraviolet Light Arch Dermatol, May 1, 1979; 115(5): 567 - 570. [Abstract] [PDF]

				H. H. Roenigk Jr and J. S. Martin Photochemotherapy for Psoriasis Arch Dermatol, December 1, 1977; 113(12): 1667 - 1670. [Abstract] [PDF]

				R. Moller and J. Howitz Methoxsalen and Multiple Basal Cell Carcinomas Arch Dermatol, November 1, 1976; 112(11): 1613 - 1614. [Abstract] [PDF]

				K. Wolff, T. B. Fitzpatrick, J. A. Parrish, F. Gschnait, B. Gilchrest, H. Honigsmann, M. A. Pathak, and L. Tannenbaum Photochemotherapy for Psoriasis With Orally Administered Methoxsalen Arch Dermatol, July 1, 1976; 112(7): 943 - 950. [Abstract] [PDF]

				H. H. Seliger, W. H. Biggley, and J. P. Hamman Long-Lived Chemiluminescence in Cigarette Smoke Science, July 19, 1974; 185(4147): 253 - 256. [Abstract] [PDF]

				T. B. FITZPATRICK, K. A. ARNDT, A. M. E. MOFTY, and M. A. PATHAK Hydroquinone and Psoralens in the Therapy of Hypermelanosis and Vitiligo Arch Dermatol, May 1, 1966; 93(5): 589 - 600. [Abstract] [PDF]

				R. E. HAKIM, A. C. GRIFFIN, and J. M. KNOX Erythema and Tumor Formation in Methoxsalen-Treated Mice Exposed to Fluorescent Light Arch Dermatol, October 1, 1960; 82(4): 572 - 577. [Abstract] [PDF]